Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001437749-15-003988
Filing Date
2015-03-03
Accepted
2015-03-03 17:06:40
Documents
15
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K insy20141231_10k.htm 10-K 2047202
2 EXHIBIT 4.1 ex4-1.htm EX-4.1 1333
3 EXHIBIT 23.1 ex23-1.htm EX-23.1 3865
4 EXHIBIT 31.1 ex31-1.htm EX-31.1 18496
5 EXHIBIT 31.2 ex31-2.htm EX-31.2 18619
6 EXHIBIT 32 ex32.htm EX-32 9635
13 b2.jpg GRAPHIC 210240
14 b1.jpg GRAPHIC 339258
15 insy20141231_10kimg001.jpg GRAPHIC 9516
  Complete submission text file 0001437749-15-003988.txt   10185939

Data Files

Seq Description Document Type Size
7 EXHIBIT 101.INS insy-20141231.xml EX-101.INS 1289000
8 EXHIBIT 101.SCH insy-20141231.xsd EX-101.SCH 58719
9 EXHIBIT 101.CAL insy-20141231_cal.xml EX-101.CAL 52087
10 EXHIBIT 101.DEF insy-20141231_def.xml EX-101.DEF 427117
11 EXHIBIT 101.LAB insy-20141231_lab.xml EX-101.LAB 375071
12 EXHIBIT 101.PRE insy-20141231_pre.xml EX-101.PRE 455524
Mailing Address 10220 SOUTH 51ST STREET SUITE 2 PHOENIX AZ 85044
Business Address 10220 SOUTH 51ST STREET SUITE 2 PHOENIX AZ 85044 602-910-2617
Insys Therapeutics, Inc. (Filer) CIK: 0001516479 (see all company filings)

EIN.: 510327886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35902 | Film No.: 15670121
SIC: 2834 Pharmaceutical Preparations